Company news
Daito Pharmaceutical Co., Ltd. (TSE:4577) news
Daito Pharmaceutical Co., Ltd. news releases on 6ix. Latest, Sep 30, 2026: Execution of JV and Share Transfer Agreement for Transfer of KYORIN…
Press releases & updates
Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical's Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ
September 30, 2026
FY2026 4Q Earnings Presentation
July 15, 2026
Notice Regarding the Results and Completion of the Acquisition of Treasury Shares Through Off-Auction Own Share Repurchase Transaction (ToSTNet-3)
July 12, 2026
Summary of Consolidated Financial Results for the Fiscal Year Ended May 31,2026 (Under Japanese GAAP)
July 10, 2026
PeptiDream Announces First Dosing of Claudin18.2 Targeting Radiopharmaceutical Candidate 64Cu-PD-29875 in Patients with Gastric Cancer
June 11, 2026
Daito Pharmaceutical : Summary of Consolidated Financial Results for the Six Months Ended November 30, 2025 (Under Japanese GAAP)
January 14, 2026
Daito Pharmaceutical : Summary of Consolidated Financial Results for the Three Months Ended August 31, 2024(Based on Japanese GAAP)
October 10, 2024
Daito Pharmaceutical : Summary of Consolidated Financial Results for the Year Ended May 31, 2024(Based on Japanese GAAP)
July 11, 2024
Daito Pharmaceutical : Summary of Consolidated Financial Results for the Three Months Ended August 31, 2023 (Japanese GAAP)
October 11, 2023
Daito Pharmaceutical : Summary of Consolidated Financial Results for the Year Ended May 31, 2023 (Based on Japanese GAAP)
July 13, 2023